Dr. Sharma is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
133 Brookline Ave
Boston, MA 02215Phone+1 617-421-5950Fax+1 617-421-6008
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2003
Tufts Medical CenterResidency, Internal Medicine, 1998 - 2001
Tufts University School of MedicineClass of 1998
Certifications & Licensure
MA State Medical License 2001 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Publications & Presentations
PubMed
- CSF1R Inhibition in Patients with Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase I Study of Vimseltinib.Hans Gelderblom, Albiruni A Razak, Matthew H Taylor, Todd M Bauer, Breelyn Wilky
Clinical Cancer Research. 2024-09-13 - 3 citationsThe MOTION study: a randomized, phase III study of vimseltinib for the treatment of tenosynovial giant cell tumor.William D Tap, Maitreyi G Sharma, Marc Vallee, Bryan D Smith, Matthew L Sherman
Future Oncology. 2024-03-01 - 26 citationsVimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by Macrophages.Bryan D. Smith, Michael Kaufman, Scott C. Wise, Yu Mi Ahn, Timothy M. Caldwell
Molecular Cancer Therapeutics. 2021-09-02
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
